Literature DB >> 15304189

A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.

Liliana Elizabeth Espinal-Perez1, Benjamin Moncada, Juan Pablo Castanedo-Cazares.   

Abstract

BACKGROUND: Melasma is an acquired treatment-resistant hyperpigmentation of the skin.
METHODS: Sixteen women with idiopathic melasma were included in our trial. After randomization by another clinician, they were instructed to use, at night, 5% ascorbic acid cream on one side of the face and 4% hydroquinone cream on the other side, for 16 weeks. Sunscreen was applied daily throughout the period of observation. They were evaluated every month by colorimetry, digital photography, and regular color slides. Subjective evaluation by each patient was also taken into account.
RESULTS: The best subjective improvement was observed on the hydroquinone side with 93% good and excellent results, compared with 62.5% on the ascorbic acid side (P < 0.05); however, colorimetric measures showed no statistical differences. Side-effects were present in 68.7% (11/16) with hydroquinone vs. 6.2% (1/16) with ascorbic acid.
CONCLUSION: Although hydroquinone showed a better response, ascorbic acid may play a role in the therapy of melasma as it is almost devoid of side-effects; it could be used alone or in combination therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304189     DOI: 10.1111/j.1365-4632.2004.02134.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  21 in total

1.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivatives.

Authors:  Chien-Yu Hsiao; Chun-Hsun Huang; Sindy Hu; Yu-Shien Ko; Hsin-Ching Sung; Shih-Yi Huang
Journal:  Lasers Med Sci       Date:  2010-12-01       Impact factor: 3.161

3.  Transdermal delivery of three vitamin C derivatives by Er:YAG and carbon dioxide laser pretreatment.

Authors:  Chun-Hsun Huang; Hsin-Ching Sung; Chien-Yu Hsiao; Sindy Hu; Yu-Shien Ko
Journal:  Lasers Med Sci       Date:  2012-07-24       Impact factor: 3.161

Review 4.  Natural Cosmeceutical Ingredients for the Management of Hyperpigmentation in Hispanic and Latino Women.

Authors:  Michael J Murphy; Aileen A Dow
Journal:  J Clin Aesthet Dermatol       Date:  2021-08-01

Review 5.  Topical Treatments for Melasma and Their Mechanism of Action.

Authors:  Valeria González-Molina; Alicia Martí-Pineda; Noelani González
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

Review 6.  Dermatology: how to manage facial hyperpigmentation in skin of colour.

Authors:  Siddiq Moolla; Yvette Miller-Monthrope
Journal:  Drugs Context       Date:  2022-05-31

Review 7.  Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications.

Authors:  Firas Al-Niaimi; Nicole Yi Zhen Chiang
Journal:  J Clin Aesthet Dermatol       Date:  2017-07-01

8.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

9.  Cosmeceuticals for Hyperpigmentation: What is Available?

Authors:  Rashmi Sarkar; Pooja Arora; K Vijay Garg
Journal:  J Cutan Aesthet Surg       Date:  2013-01

10.  A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment.

Authors:  Vidyadhar R Sardesai; Jennifer N Kolte; Babu N Srinivas
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.